Norethindrone Acetate/Ethinyl Estradiol

醋炔诺酮/炔雌醇

Report date: 2026/05/07 20:00:36

Base Information

Drug NameNorethindrone Acetate/Ethinyl Estradiol
Drug Alias NameFemlyv
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsProgesterone receptorEstrogen receptors
Therapy Area/IndicationsContraceptionDiabetes Insipidus, NeurogenicHypopituitarism
Global Approved IndicationsContraception
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/07/22
Country/TerritoryUnited States
CombinationsYes Norethindrone AcetateEthinyl Estradiol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesMillicent Puerto Rico LLCMassachusetts General Hospital
Inactive CompaniesN/A
Active IndicationsContraceptionDiabetes Insipidus, NeurogenicHypopituitarism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A